Guangdong Lifestrong Pharmacy Co. Ltd. (301111) — Free Cash Flow Generation Index

Latest as of September 2025: 0.90x

Guangdong Lifestrong Pharmacy Co. Ltd. (301111) has a Free Cash Flow Generation Index of 0.90x as of September 2025. Free cash flow of CN¥7.00 Million represents 1% of operating cash flow (CN¥7.75 Million). Explore reinvestment intensity of Guangdong Lifestrong Pharmacy Co. Ltd. to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.90x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥7.00 Million
CNY

Operating Cash Flow

CN¥7.75 Million
CNY

Capital Expenditures

CN¥748.65K
CNY

Guangdong Lifestrong Pharmacy Co. Ltd. Free Cash Flow Generation Index (2017–2025)

Historical FCF Generation Index trend for Guangdong Lifestrong Pharmacy Co. Ltd. across 8 annual periods. For the full cash flow conversion analysis, see Guangdong Lifestrong Pharmacy Co. Ltd. operating cash flow efficiency.

Annual Free Cash Flow Generation for Guangdong Lifestrong Pharmacy Co. Ltd. (2017–2025)

Year-by-year Free Cash Flow Generation Index for Guangdong Lifestrong Pharmacy Co. Ltd.. Check cash flow reinvestment rate of Guangdong Lifestrong Pharmacy Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.08x CN¥803.35K CN¥10.58 Million CN¥9.78 Million ▲ +100.7%
2024 -10.81x CN¥-34.69 Million CN¥3.21 Million CN¥37.90 Million ▼ -1274.2%
2022 0.92x CN¥64.34 Million CN¥69.88 Million CN¥5.54 Million ▼ -3.8%
2021 0.96x CN¥68.54 Million CN¥71.63 Million CN¥3.09 Million ▲ +94.1%
2020 0.49x CN¥44.80 Million CN¥90.90 Million CN¥46.10 Million ▼ -33.1%
2019 0.74x CN¥35.88 Million CN¥48.70 Million CN¥12.83 Million ▼ -23.8%
2018 0.97x CN¥40.05 Million CN¥41.40 Million CN¥1.35 Million ▲ +26.3%
2017 0.77x CN¥5.40 Million CN¥7.04 Million CN¥1.65 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).